Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Philips to ramp up production of ventilators in coronavirus fight

Published 03/22/2020, 05:00 PM
Updated 03/22/2020, 05:05 PM

AMSTERDAM (Reuters) - Dutch health technology company Philips (AS:PHG) is to ramp up production of critical healthcare products to help diagnose and treat patients with the new coronavirus disease COVID-19.

Philips said on Sunday that it aimed to double its production of hospital ventilators within the next eight weeks and to achieve a four-fold increase by the third quarter.

"We currently make around a thousand ventilators per week and are looking to reach around 2,000 in the coming weeks," Chief Executive Frans van Houten told Reuters.

"We will continue to increase production, because we see an enormous demand."

Van Houten said he had been in contact with his main competitors, such as Draeger (DE:DRWG) and Medtronic (N:MDT), who he said were also aiming to increase production.

"Our increase alone will certainly not be enough," he said. "But together, we hope to come towards meeting demand."

Van Houten said Philips also hopes to increase production of other equipment critical in the fight against COVID-19, such as vital signs monitors, diagnostic imaging systems and software solutions for hospitals to monitor and manage patients in intensive care units.

For this, Philips expects to hire extra manufacturing staff as well as shifting current staff to the production lines where they are most needed.

"But the most important part is to get suppliers to cooperate, to facilitate the ramp-up in production", Van Houten said.

Despite the increased demand for its critical healthcare equipment, Philips said it expected the coronavirus outbreak to harm its results in the first half of 2020.

Philips had earlier already warned about the impact of the pandemic on first-quarter earnings because demand for its consumer products has waned and global supply chains have been severely disrupted.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.